The transaction, approved by the board of directors of Emami, involves an aggregate consideration not exceeding Rs 200 crore
Emami, a key player in India’s personal care and healthcare sector, has executed a definitive agreement to acquire the remaining around 73.5 per cent stake in Axiom Ayurveda (Axiom) subject to completion of customary closing conditions.
In the first tranche, Emami acquired around 36.7 per cent additional stake (existing stake around 26.5 per cent). While the definitive agreement was executed recently, the acquisition is expected to be completed in a phased manner over the next three months, in accordance with the terms of the agreement and applicable regulatory requirements.
The transaction, approved by the board of directors of Emami, involves an aggregate consideration not exceeding Rs 200 crore. Axiom’s portfolio includes beverage products under the brand AloFrut, health juices under the brand Axiom Jeevan Ras, and beauty products under the brand Mukti Gold.
“Our growth strategy is centered on building presence in emerging, high-opportunity categories that align with evolving consumer preferences, particularly in the health and wellness space. Our partnership with Axiom over the past two and half years has provided us with valuable insights and strengthened our conviction in this segment,” stated Harsha Vardhan Agarwal, Vice Chairman and Managing Director (MD), Emami.
As Axiom enters its next phase of growth under Emami’s leadership, the company has onboarded Harkirat Bedi (formerly Vice President and Business Head at Dabur Nepal) as the Chief Executive Officer of Axiom Ayurveda. His appointment is expected to further strengthen the leadership team and accelerate the company’s expansion in the health and wellness beverage segment.
Agarwal pointed out that Axiom is a profitable and growing company, expected to achieve a topline of around Rs 180 crore in the financial year 2026, as per the company’s exchange filing.
